Back to Directory
GLP-2 Analog (Teduglutide)
Performance & EnduranceGLP-2 analog for short bowel syndrome, promotes intestinal growth and function.
Key Benefits
- ✓Promotes intestinal growth
- ✓Improves nutrient absorption
- ✓Reduces parenteral nutrition needs
- ✓Treats short bowel syndrome
- ✓Enhances intestinal adaptation
Dosing Information
Dosage Range
0.05 mg/kg
Frequency
Once daily
Typical Duration
Ongoing
Detailed Protocol
Administered via subcutaneous injection once daily. Requires prescription and medical supervision. Dose based on body weight. Specialized use for SBS patients.
About GLP-2 Analog (Teduglutide)
Teduglutide (Gattex, Revestive) is a synthetic analog of GLP-2 (glucagon-like peptide-2) that promotes intestinal mucosal growth and function. FDA-approved for short bowel syndrome to reduce parenteral nutrition dependence.
Research Notes
FDA-approved in 2012 for short bowel syndrome. Clinical trials show reduced need for parenteral support. Requires monitoring for intestinal polyps/tumors.
Potential Side Effects
- •Abdominal pain
- •Injection site reactions
- •Nausea
- •Fluid overload
- •Colonoscopy surveillance needed
- •Possible tumor growth concerns
Always consult with a healthcare professional before starting any peptide therapy.